LifeMD, Inc.
$5.06
▼
-1.96%
2026-04-21 07:52:00
lifemd.com
NGM: LFMD
Explore LifeMD, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$242.75 M
Current Price
$5.06
52W High / Low
$15.84 / $2.56
Stock P/E
15.69
Book Value
$0.5
Dividend Yield
1.28%
ROCE
-26.6%
ROE
-1.31%
Face Value
—
EPS
$-0.3
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
347
Beta
1.77
Debt / Equity
27.31
Current Ratio
1.25
Quick Ratio
1.18
Forward P/E
7.8
Price / Sales
0.86
Enterprise Value
$136.01 M
EV / EBITDA
-20.27
EV / Revenue
0.7
Rating
None
Target Price
$9.88
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
| 2. | Schrödinger, Inc. | $12.8 | — | $944.96 M | — | -31.08% | -26.29% | $27.63 / $10.95 | $4.94 |
| 3. | Claritev Corporation | $22.45 | — | $349.35 M | — | 0.97% | 632.6% | $74.07 / $12.04 | $-10.51 |
| 4. | Healthcare Triangle, Inc. | $2.47 | — | $4.86 M | — | 89.58% | -1.83% | $7,470 / $2.24 | $17.67 |
| 5. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 6. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 7. | DarioHealth Corp. | $7.46 | — | $54.46 M | — | -36.38% | -59.62% | $17.74 / $5.93 | $9.84 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 7.08 M | 60.17 M | 62.22 M | 65.7 M | 64.25 M | — |
| Operating Profit | -6.22 M | -1.97 M | -0.91 M | 2.54 M | 1.02 M | — |
| Net Profit | 19.96 M | -3.81 M | -2.07 M | 1.38 M | -0.11 M | — |
| EPS in Rs | 0.42 | -0.08 | -0.04 | 0.03 | -0 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 194.06 M | 154.82 M | 152.55 M | 119.03 M |
| Operating Profit | -7.67 M | -20.4 M | -14.49 M | -39.69 M |
| Net Profit | 14.35 M | -21.41 M | -20.6 M | -45.54 M |
| EPS in Rs | 0.3 | -0.45 | -0.44 | -0.96 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 70.41 M | 76.1 M | 58.48 M | 25.67 M |
| Total Liabilities | 47.25 M | 83.65 M | 52.91 M | 32.97 M |
| Equity | 23.16 M | -9.08 M | 3.51 M | -6.83 M |
| Current Assets | 51.83 M | 52.37 M | 42.6 M | 11.31 M |
| Current Liabilities | 41.57 M | 67.4 M | 34.78 M | 31.37 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 8.28 M | 17.51 M | 8.82 M | -22.94 M |
| Investing CF | 6.91 M | -11.54 M | -8.73 M | -13.91 M |
| Financing CF | -13.41 M | -4.12 M | 29.1 M | -0.53 M |
| Free CF | -1.24 M | 9.31 M | 0.09 M | -35.83 M |
| Capex | -9.52 M | -8.2 M | -8.73 M | -12.89 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1.49% | 28.15% | — | — |
| Earnings Growth % | -3.95% | 54.77% | — | — |
| Profit Margin % | -13.83% | -13.5% | -38.25% | — |
| Operating Margin % | -13.18% | -9.5% | -33.34% | — |
| Gross Margin % | 86.15% | 87.61% | 84.32% | — |
| EBITDA Margin % | -9.18% | -5.17% | -30.17% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.